NDAORALSOLUTION
Approved
Dec 1999
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Clinical Trials
2
Data completeness
4/8 — Partial
CELEXA (citalopram hydrobromide) by Forest Devices is unclear, but is presumed to be related to potentiation of serotonergic activity in the central nervous system (cns) resulting from its inhibition of cns neuronal reuptake of serotonin (5-ht). First approved in 1999.
Drug data last refreshed 12h ago · AI intelligence enriched Yesterday
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
CELEXA (citalopram hydrobromide) is an oral selective serotonin reuptake inhibitor (SSRI) approved in 1999 for major depressive disorder. It works by inhibiting neuronal reuptake of serotonin in the central nervous system, potentiating serotonergic activity. The drug is a foundational antidepressant in the competitive CNS therapeutic landscape.
$3MPart D
LOE ApproachingDeclining
Mature product approaching loss of exclusivity with minimal generic barrier; team likely focused on managed care, compliance, and defensive positioning rather than growth.
Mechanism of Action
unclear, but is presumed to be related to potentiation of serotonergic activity in the central nervous system (CNS) resulting from its inhibition of CNS neuronal reuptake of serotonin (5-HT).
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Clinical Trials (2)
Bioequivalence Study of Citalopram Hydrobromide Tablets 40 mg of Dr.Reddy's Laboratories Limited Under Fasting Conditions
Started Oct 2003
24 enrolled
Healthy
Bioequivalence Study of Citalopram Hydrobromide Tablets 40 mg of Dr.Reddy's Laboratories Limited Under Fed Conditions
Started Oct 2003
24 enrolled
Healthy
Career Relevance
Working on CELEXA means operating in a mature, highly competitive therapeutic area with limited growth opportunities. Career trajectory favors those skilled in managed care negotiation, defensive positioning, and cost optimization rather than market expansion.
Brand Manager
Worked on CELEXA at Forest Devices? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.